Reviewer Board
Members of the reviewer board are selected from all Cancers reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
Interests: extracellular vesicles; glioma; neurosurgery; methylation; brain metastasis
Interests: extracellular vesicles; glioma; neurosurgery; methylation; brain metastasis
Radboud University Medical Centre, Nijmegen, The Netherlands
Interests: cancer chemoresistance; multidrug resistance; drug transporters; nuclear receptors; extracellular vesicles; exosomes; purinergic signaling
Interests: cancer chemoresistance; multidrug resistance; drug transporters; nuclear receptors; extracellular vesicles; exosomes; purinergic signaling
1. Department of Surgery, Akershus University Hospital, 1478 Lørenskog, Norway
2. Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway
Interests: breast cancer, surgery, oncology
2. Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway
Interests: breast cancer, surgery, oncology
Cancer Heterogeneity and Hierarchies Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain
Interests: stem cells; breast cancer; Notch signalling; senescence; lineage tracing; basic reserach
Interests: stem cells; breast cancer; Notch signalling; senescence; lineage tracing; basic reserach
Biodonostia Health Research Institute, San Sebastian, Spain
Interests: non-alcoholic fatty liver disease (nafld); liver cancer; Hepatocellular Carcinoma; Cholangiocarcinoma; Molecular pathogenesis; therapeutic targets; molecular and cellular biology; mirnas; biomarkers
Interests: non-alcoholic fatty liver disease (nafld); liver cancer; Hepatocellular Carcinoma; Cholangiocarcinoma; Molecular pathogenesis; therapeutic targets; molecular and cellular biology; mirnas; biomarkers
1. Maimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain
2. Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd), 28029 Madrid, Spain
3. Department of Hepatology and Liver Transplantation, Reina Sofia University Hospital, 14004 Cordoba, Spain
Interests: Hepatocellular Carcinoma; liver transplantation; Immunosuppression; liver cancer
2. Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd), 28029 Madrid, Spain
3. Department of Hepatology and Liver Transplantation, Reina Sofia University Hospital, 14004 Cordoba, Spain
Interests: Hepatocellular Carcinoma; liver transplantation; Immunosuppression; liver cancer
Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine “López-Neyra”, IPBLN, CSIC, CIBERONC, 18016 Granada, Spain
Interests: parp3 parylation cancer neural differentiation; PARP1 HIF1alpha hypoxia cancer
Interests: parp3 parylation cancer neural differentiation; PARP1 HIF1alpha hypoxia cancer
Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: melanoma, drug resistance, immunotherapy
Interests: melanoma, drug resistance, immunotherapy
Program in Emerging Infectious Diseases, Duke-NUS Medical School Singapore, Singapore 169857, Singapore
Interests: flaviviruses; immunity; antibody-dependent enhancement; immunometabolism; vaccine
Interests: flaviviruses; immunity; antibody-dependent enhancement; immunometabolism; vaccine
Ragon Institute of MGH, MIT and Harvard University, 400 Technology Square, Cambridge, MA, USA
Interests: HIV; influenza; SARS-CoV2; COVID-19; AIDS; B cell receptor sequencing; immunity; vaccination
Interests: HIV; influenza; SARS-CoV2; COVID-19; AIDS; B cell receptor sequencing; immunity; vaccination
Institute of Pathology, Oncological Pathology Group, Hospital of the RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
Interests: epigenetics; (epi)genetic biomarkers; class-II tumor suppressor genes; cancer metastasis; tumor microenvironment; drug development
Interests: epigenetics; (epi)genetic biomarkers; class-II tumor suppressor genes; cancer metastasis; tumor microenvironment; drug development
Unit of Pharmaceutics and Biopharmaceutics, Université libre de Bruxelles (ULB), 50-1050 Brussels, Belgium
Interests: inhalation; controlled-release; nanomedicine; Dry-powder for inhalation (DPI); nose-to-brain delivery; chemotherapy; oncology; lung cancer
Interests: inhalation; controlled-release; nanomedicine; Dry-powder for inhalation (DPI); nose-to-brain delivery; chemotherapy; oncology; lung cancer
Mathieu Roumiguie Department of Urology CHU/IUCT Oncopole Toulouse, 31076 Toulouse, France
Interests: diagnosis of proastate cancer; bladder cancer; urothelial carcinoma
Interests: diagnosis of proastate cancer; bladder cancer; urothelial carcinoma
Department of Health Sciences, University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy.
Interests: oncology; genito-urinary cancer; gastro-intestinal cancer; immunotherapy
Interests: oncology; genito-urinary cancer; gastro-intestinal cancer; immunotherapy
Brain Tumour Research Centre, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UK
Interests: GBM therapeutics; molecular signature of GBM; 3D culture; immunosuppression in GBM
Interests: GBM therapeutics; molecular signature of GBM; 3D culture; immunosuppression in GBM
Department of Onco-Hematology, A.O. Papardo, 98158 Messina, Italy
Interests: cancer biomarkers; ctdna; immunotherapy; liquid biopsy; Non-small cell lung cancer; targeted therapies
Interests: cancer biomarkers; ctdna; immunotherapy; liquid biopsy; Non-small cell lung cancer; targeted therapies
Department of Urology, Goethe-Universität Frankfurt, D-60590 Frankfurt am Main, Germany
Interests: Urological tumors; proliferation; growth; phytomedicine; curcumin
Interests: Urological tumors; proliferation; growth; phytomedicine; curcumin
Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia
Interests: cytokine biology; lung cancer; KRAS; ADAM proteases; inflammation
Interests: cytokine biology; lung cancer; KRAS; ADAM proteases; inflammation
German Cancer Research Center, Heidelberg, 69120 Heidelberg, Germany
Interests: nuclear medicine; PET/CT; PET/MRI; radiopharmaceuticals; oncological imaging; multiple myeloma; melanoma; prostate cancer
Interests: nuclear medicine; PET/CT; PET/MRI; radiopharmaceuticals; oncological imaging; multiple myeloma; melanoma; prostate cancer
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Interests: tumor signaling and microenvironment; oncogene; cellular stress; ER stress; kinases; DNA damage response; immunotherapy; targeted therapy
Interests: tumor signaling and microenvironment; oncogene; cellular stress; ER stress; kinases; DNA damage response; immunotherapy; targeted therapy
Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI 48109, USA
Interests: epigenetics; gene expression; leukemia; transcriptomics; chipseq; molecular biology
Interests: epigenetics; gene expression; leukemia; transcriptomics; chipseq; molecular biology
Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
Interests: molecular oncology; cancer stem cell; signaling pathway; genomics
Interests: molecular oncology; cancer stem cell; signaling pathway; genomics
Boonshoft School of Medicine, Wright State University, 3640 Colonel Glenn Hwy, Dayton, OH 45435, USA
Interests: cacner; cancer therapeutics; lipid mediator; oxidative stressors; anti-tumor immune response; naturally occurring dietary compounds; cancer chemoprevention; cell signaling and apoptotic pathways
Interests: cacner; cancer therapeutics; lipid mediator; oxidative stressors; anti-tumor immune response; naturally occurring dietary compounds; cancer chemoprevention; cell signaling and apoptotic pathways
Associate Clinical Professor, Clinical Director, Acute Pain Service, Department of Anesthesiology, Division of Regional Anesthesia and Acute Pain, University of California, San Diego, CA 92093, USA
Interests: acute pain; regional anesthesia; multimodal analgesia; opioids; thoracic epidurals; acute pain service; peripheral nerve block
Interests: acute pain; regional anesthesia; multimodal analgesia; opioids; thoracic epidurals; acute pain service; peripheral nerve block
Otolaryngology-Head and Neck Surgery, University of Tokyo, Tokyo 113-8655, Japan
Interests: head and neck cancer; hpv; oropharyngeal carcinoma; hypopharyngeal carcinoma; biomarker
Interests: head and neck cancer; hpv; oropharyngeal carcinoma; hypopharyngeal carcinoma; biomarker
Department of Oncology, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy
Interests: biliary cancer; Cholangiocarcinoma; pancreatic cancer; gastric cancer; immunotherapy; organoids; clinical trials; ctdna; liquid biopsy; translational research
Interests: biliary cancer; Cholangiocarcinoma; pancreatic cancer; gastric cancer; immunotherapy; organoids; clinical trials; ctdna; liquid biopsy; translational research
School of Science,
Constructor University Bremen gGmbH,
Germany
Interests: systems biology; cancer metabolism; data integration; metabolic modeling; omics data analysis; network biology; protein-protein interaction network; kinetic modeling; genome-scale metabolic model; constraint-based modeling
Interests: systems biology; cancer metabolism; data integration; metabolic modeling; omics data analysis; network biology; protein-protein interaction network; kinetic modeling; genome-scale metabolic model; constraint-based modeling
Laboratory of Translational Research, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy
Interests: lung cancer; thyroid cancer; melanoma; HDAC inhibitors; BET inhibitors; drug resistance; CRISPR/Cas9 screening; hippo
Interests: lung cancer; thyroid cancer; melanoma; HDAC inhibitors; BET inhibitors; drug resistance; CRISPR/Cas9 screening; hippo
Department of Oncology, Georgetown University, Washington, DC 20057, USA
Interests: personalized medicine; immune checkpoints inhibitors; liver cirrhosis; Hepatocellular Carcinoma; nonalcoholic steatohepatitis; proteogenomics; bio-marker; glycosylation
Interests: personalized medicine; immune checkpoints inhibitors; liver cirrhosis; Hepatocellular Carcinoma; nonalcoholic steatohepatitis; proteogenomics; bio-marker; glycosylation
Swiss Institute for Experimental Cancer Research, EPFL, CH-1015 Lausanne, Switzerland
Interests: metastasis; tumor microenvironment; cancer stem cells; extracellular matrix; breast cancer; prostate cancer; obesity; lymphoma
Interests: metastasis; tumor microenvironment; cancer stem cells; extracellular matrix; breast cancer; prostate cancer; obesity; lymphoma
